Open Access Highly Accessed Review

Circulating microparticles: square the circle

Natasha S Barteneva12*, Elizaveta Fasler-Kan34, Michael Bernimoulin5, Joel NH Stern6, Eugeny D Ponomarev78, Larry Duckett9 and Ivan A Vorobjev10

Author Affiliations

1 Program in Cellular and Molecular Medicine, Boston Children’s Hospital, D-249, 200 Longwood Avenue, Boston, MA 02115, USA

2 Department of Pediatrics, Harvard Medical School, Boston, MA, USA

3 Institute of Chemistry and Bioanalytics, University of Applied Sciences Northwestern Switzerland (FHNW), Muttenz, Switzerland

4 Department of Biomedicine, University Hospital Basel, Basel, Switzerland

5 Division of Hematology, University Hospital, Geneva, Switzerland

6 Department of Developmental Biology, Harvard School of Dental Medicine, Boston, MA, USA

7 Center for Neurologic Disease, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

8 Thematic Research Program for Neurodegeneration, Development and Repair, School for Biomedical Sciences, The Chinese University of Hong Kong, Shatin, NT, Hong Kong

9 BD Biosciences Inc, San Jose, CA, USA

10 A.N. Belozersky Institute for Physico-Chemical Biology and Department of Cell Biology, Biological Faculty, M.V. Lomonosov Moscow State University, Moscow, Russia

For all author emails, please log on.

BMC Cell Biology 2013, 14:23  doi:10.1186/1471-2121-14-23

Published: 22 April 2013

Additional files

Additional file 1:

Range of MP sizes in different publications.

Format: DOC Size: 42KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 2:

References for Table 1 (Summary of some methods applied for MPs research).

Format: DOC Size: 38KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 3:

MP-based risk stratification of some pathological states.

Format: DOC Size: 54KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 4:

Supplemental Table. Changes in MP levels in peripheral blood of patients in response to treatments.

Format: DOC Size: 45KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 5:

References for Table 2 (MP levels in the plasma of healthy controls).

Format: DOC Size: 35KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 6:

References for Table 3 (MP levels in the plasma and body fluids of patients with cancer).

Format: DOC Size: 42KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 7:

References for Table 4 (MP levels in the plasma and body fluids of patients with different disorders).

Format: DOC Size: 112KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data